Mutual Funds

WOC Pharma and Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

16.78 -0.05
NAV(₹) as on 14/8/2026

-0.28%
1D

19.70%
1Y

-
3Y

-
5Y

WOC Pharma and Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.84	Launch Date: 06 Feb 2024
Exit Load: NIL	AUM: ₹ 824.90 Crs
Lock-in: Nil	Investing Style: Large Growth
Portfolio Price To Book Value: 10.26	Min. Investment: SIP : ₹ 100.00 Lumpsum : ₹ 500.00
Scheme Benchmark: NA
Fund Manager: Ramesh Mantri ,Dheeresh Pathak ,Piyush Baranwal

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Debt		Equity
as on 31/7/2026		2.16 %		3.38 %		94.46 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

8.53 %

Torrent Pharmaceuticals Ltd.

7.81 %

Laurus Labs Ltd.

4.94 %

Apollo Hospitals Enterprise Ltd.

4.78 %

Divi's Laboratories Ltd.

3.86 %

Max Healthcare Institute Ltd.

3.76 %

Cipla Ltd.

3.72 %

Sai Life Sciences Ltd.

3.18 %

Zydus Lifesciences Ltd.

2.94 %

Neuland Laboratories Ltd.

2.87 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

59.71 %

Hospital & Healthcare Servic

27.61 %

Chemicals

3.40 %

Plastic Products

1.39 %

Medical Equipment/Supplies/A

1.14 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2023-24	2024-25	2025-26
NAV (31/3/2026)	9.96	12.74	13.39
Net Assets (Rs Crores)	10,860.86	30,362.42	55,641.96
Scheme Returns(%)(Absolute)	-0.44	26.85	6.90
B'mark Returns(%)(Absolute)	NA	NA	NA
Category Rank	85/90	2/102	8/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 21.42 +-0.01	4/10/2023	₹ 2,939.98	23.63%	-	-	30.64%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.78 +-0.05	6/2/2024	₹ 824.9	19.70%	-	-	22.80%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 12.14 +-0.03	6/12/2024	₹ 111.64	21.89%	-	-	12.18%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.65 +-0.09	27/12/2024	₹ 376.77	19.42%	-	-	9.83%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.69 +-0.05	27/6/2025	₹ 519.48	8.54%	-	-	6.08%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.24 +-0.01	28/11/2025	₹ 319.48	-	-	-	12.37%
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.66 +0.03	11/12/2023	₹ 682.39	22.53%	-	-	21.02%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 18.03 +-0.06	8/11/2021	₹ 262.84	10.34%	18.08%	-	13.16%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 573.15 +-1.29	5/6/2004	₹ 9,279.11	10.32%	18.10%	13.38%	20.00%
Tata India Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 33.63 +-0.05	28/12/2015	₹ 1,541.42	8.37%	18.59%	13.82%	12.08%